ITA
ENGInfectious agents and atherosclerosis: current perspectives and unsolved issues
Infectious agents and atherosclerosis: current perspectives and unsolved issues
In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy
In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy
Transmural coronary inflammation triggers simultaneous multivessel rupture of unstable plaques
Transmural coronary inflammation triggers simultaneous multivessel rupture of unstable plaques
Original articles Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes
Original articles Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes
C-reactive protein: risk assessment in the primary prevention of atherosclerotic disease. Has the time come for including it in the risk profile?
C-reactive protein: risk assessment in the primary prevention of atherosclerotic disease. Has the time come for including it in the risk profile?
Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease
Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease
C-reactive protein and atherothrombosis
C-reactive protein and atherothrombosis
C-reactive protein and its role in the pathogenesis of myocardial infarction
C-reactive protein and its role in the pathogenesis of myocardial infarction
Inflammatory mechanisms in atherosclerosis: from laboratory evidence to clinical application
Inflammatory mechanisms in atherosclerosis: from laboratory evidence to clinical application
C-reactive protein and atherosclerosis: Quo Vadis?
C-reactive protein and atherosclerosis: Quo Vadis?
